Alexander D. Douglas

University College Dublin — Ireland

Medicine · Health Sciences

43h-index17.6kcitations102works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(38), Mosquito-borne diseases and control(29), SARS-CoV-2 and COVID-19 Research(23), HIV Research and Treatment(16), Virus-based gene therapy research(16)

Publications102 total

The impact of the COVID-19 pandemic on health behaviours of primary school children in Ireland
European Journal of Public Health·2025Open Access
Rabies glycoprotein engineering for improved stability and expression
Vaccine·2025Open Access
Routine childhood rabies pre-exposure prophylaxis can be cost effective in low- and middle-income countries
Vaccine·2025· 3 citedOpen Access
Contributors
Elsevier eBooks·2025
Adenoviral vaccines—Infectious disease
Elsevier eBooks·2025
Health disparities continue to report in DEIS schools: Irish COSI Round 6 study
European Journal of Public Health·2024Open Access
Disparities in Breastfeeding Patterns Persist Despite Improved Rates: Findings from Irish COSI R6
European Journal of Public Health·2024Open Access
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Nature Communications·2024· 27 citedOpen Access
A screen for Plasmodium falciparum sporozoite surface protein binding to human hepatocyte surface receptors identifies novel host–pathogen interactions
Malaria Journal·2024· 5 citedOpen Access
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
2024· 1 citedOpen Access
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
Wellcome Open Research·2023· 7 citedOpen Access
Accelerated and intensified manufacturing of an adenovirus‐vectored vaccine to enable rapid outbreak response
Biotechnology and Bioengineering·2023· 11 citedOpen Access
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
npj Vaccines·2023· 12 citedOpen Access
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
Wellcome Open Research·2023· 1 citedOpen Access
Rapid-response manufacturing of adenovirus-vectored vaccines
Nature Biotechnology·2023· 20 citedOpen Access
Associations between maternal dietary scores during early pregnancy with placental outcomes
Frontiers in Nutrition·2023· 5 citedOpen Access
Measurement of Adenovirus-Based Vector Heterogeneity
Journal of Pharmaceutical Sciences·2022· 9 citedOpen Access
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
EBioMedicine·2022· 138 citedOpen Access
A screen for Plasmodium falciparum sporozoite surface protein binding to human hepatocyte surface receptors identifies novel host-pathogen interactions
Research Square (Research Square)·2022· 1 citedOpen Access
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
Scientific Reports·2022· 7 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Adrian V. S. Hill(32), Simon J. Draper(28), Sarah C. Gilbert(25), Katie Ewer(16), Angela M. Minassian(15), Alison M. Lawrie(14), Teresa Lambe(14), Nick J. Edwards(14), Pedro M. Folegatti(13), Daniel Jenkin(13), Parvinder K. Aley(12), Sagida Bibi(12), Saul N. Faust(12), Anna L. Goodman(12), Maheshi Ramasamy(12), Andrew J. Pollard(12), Kazutoyo Miura(12), Carole A. Long(12), Paola Cicconi(11), Catherine Green(11)